February 25, 2014
ARLINGTON, Va. — HDMA President and CEO John M. Gray released the following statement on the National Governors Association's (NGA's) February 23 report, "Reducing Prescription Drug Abuse: Lessons Learned from an NGA Policy Academy."
“HDMA applauds the NGA for addressing our nation’s ongoing prescription drug abuse epidemic by convening a variety of stakeholders — including HDMA — to participate in its Prescription Drug Abuse Reduction Policy Academy. We are pleased that the discussions from the Policy Academy have resulted in thoughtful observations and recommendations.
“Like the NGA, HDMA believes that reducing this public health issue requires a multifaceted approach that fosters collaboration and consensus among stakeholders. We also agree that policymakers will need to be mindful of potential unintended consequences that may occur from adopting certain solutions, which may hamper legitimate patient access to medicines. HDMA and the nation’s primary healthcare distributors look forward to working with the NGA, and others, as it continues this initiative, as we work together to eradicate prescription drug abuse in the U.S.”
For further HDMA resources on prescription drug abuse, see the Association's “Guiding Industry Principles on Prescription Drug Abuse and Diversion” and the fact sheet, “Fighting an Epidemic.”
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.